Subject(s)
Exercise Test , Neoplasms , Humans , Preoperative Care , Risk Assessment , Neoplasms/surgeryABSTRACT
Cardiopulmonary exercise testing (CPET) is used as a risk stratification tool for patients undergoing major surgery. In this study, we investigated the role of CPET in predicting day five cardiopulmonary morbidity in patients undergoing head and neck surgery. This observational cohort study included 230 adults. We recorded preoperative CPET variables and day five postoperative cardiopulmonary morbidity. Full data from 187 patients were analysed; 43 patients either had incomplete data sets or declined surgery/CPET. One hundred and nineteen patients (63.6%) developed cardiopulmonary morbidity at day five. Increased preoperative heart rate and duration of surgery were independently associated with day five cardiopulmonary morbidity. Those with such morbidity also had lower peak VÌO2 11.4 (IQR 8.4-18.0) vs 16.0 (IQR 14.0-19.7) ml.kg-1.min-1, P<0.0001 and VÌO2 at AT 10.6 (IQR 9.1-13.1) vs 11.5 (IQR 10.5-13.0) ml.kg-1.min-1, p=0.03. Logistic regression model containing peak VÌO2 and duration of surgery demonstrated that increased peak VÌO2 was associated with a reduction in the likelihood of cardiopulmonary complications OR 0.92 (95%CI 0.87 to 0.96), p=0.001. The area under the receiver operating characteristic curve for this model was 0.75(95%CI 0.68 to 0.82), p<0.0001, 64% sensitivity, 81% specificity. CPET can help to predict day five cardiopulmonary morbidity in the patients undergoing head and neck surgery. A model containing peak VÌO2 allowed identification of those with such complications.
Subject(s)
Exercise Test , Postoperative Complications , Adult , Humans , Logistic Models , Morbidity , Oxygen Consumption , Postoperative Complications/epidemiology , ROC CurveABSTRACT
The ATP binding cassette transporter A1 (ABCA1) mediates cellular cholesterol and phospholipid efflux, and is implicated in phosphatidylserine translocation and apoptosis. Loss of functional ABCA1 in null mice results in severe placental malformation. This study aimed to establish the placental localisation of ABCA1 and to investigate whether ABCA1 expression is altered in placentas from pregnancies complicated by pre-eclampsia and antiphospholipid syndrome. ABCA1 mRNA and protein localisation studies were carried out using in situ hybridization and immunohistochemistry. Comparisons of gene expression were performed using real-time PCR and immunoblotting. ABCA1 mRNA and protein was localised to the apical syncytium of placental villi and endothelia of fetal blood vessels within the villi. ABCA1 mRNA expression was reduced in placentas from women with APS when compared to controls (p<0.001), and this was paralleled by reductions in ABCA1 protein expression. There were no differences in ABCA1 expression between placentas from pre-eclamptic pregnancies and controls. The localisation of ABCA1 in human placenta is consistent with a role in cholesterol and phospholipid transport. The decrease in ABCA1 protein in APS may reflect reduced cholesterol transport to the fetus affecting the formation of cell membranes and decreasing the level of substrate available for steroidogenesis.
Subject(s)
ATP-Binding Cassette Transporters/metabolism , Antiphospholipid Syndrome/metabolism , Placenta/metabolism , Pre-Eclampsia/metabolism , ATP Binding Cassette Transporter 1 , ATP-Binding Cassette Transporters/analysis , ATP-Binding Cassette Transporters/genetics , Adolescent , Adult , Antiphospholipid Syndrome/genetics , Down-Regulation , Endothelium, Vascular/chemistry , Female , Gene Expression , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Placenta/chemistry , Pre-Eclampsia/genetics , Pregnancy , RNA, Messenger/analysis , RNA, Messenger/metabolismABSTRACT
Novel and diverse functions of glial cells are currently the focus of much attention [A. Volterra and J. Meldolesi (2005) Nature Rev. 6, 626-640]. Here we present evidence that rat astroglia release acetylcholinesterase (AChE) as part of their response to hypoxic damage. Exposure of astroglia to tert-butyl hydroperoxide, and hence oxidative stress, subsequently leads to a switching in mRNA from the classical membrane-bound T-AChE to a preferential increase in the splice variant for a soluble form, R-AChE, This change in expression is reflected in increased perinuclear and reduced cytoplasmic AChE staining of the insulted glial cells, with a concomitant and marked increase in extracellular secretion that peaks at 1 h post-treatment. An analogous increase in R-AChE, over a similar time scale, occurs in response to psychological stress [D. Kaufer et al. (1998) Nature 93, 373-377], as well as to head injury and stroke [E. Shohami et al. (1999) J. Neurotrauma 6, 365-76]. The data presented here suggest that glial cells may be key chemical intermediaries in such situations and, perhaps more generally in pathological conditions involving oxidative stress, such as neurodegeneration.
Subject(s)
Acetylcholinesterase/biosynthesis , Acetylcholinesterase/genetics , Astrocytes/metabolism , Brain/metabolism , Hypoxia, Brain/metabolism , Nerve Degeneration/metabolism , Oxidative Stress/physiology , Acetylcholine/biosynthesis , Acetylcholinesterase/metabolism , Alternative Splicing/physiology , Animals , Animals, Newborn , Astrocytes/drug effects , Brain/physiopathology , Cells, Cultured , Hypoxia, Brain/genetics , Hypoxia, Brain/physiopathology , Nerve Degeneration/genetics , Nerve Degeneration/physiopathology , Oxidative Stress/drug effects , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Ribosomal Proteins/biosynthesis , Ribosomal Proteins/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , Solubility , Transcriptional Activation , Up-Regulation/physiology , tert-Butylhydroperoxide/pharmacologyABSTRACT
BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) affects approximately 0.7% of pregnancies in the UK and is associated with prematurity, fetal distress, and intrauterine death. Homozygous mutations in the ATP8B1 gene cause cholestasis with a normal serum gamma-glutamyl transpeptidase (gamma-GT), and have been reported in two forms of cholestasis: progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis (BRIC). AIMS: To establish whether mutations in ATP8B1 are associated with ICP in British cases PATIENTS: Sixteen well phenotyped women with ICP without raised gamma-GT were selected for sequence analysis. Subsequently, 182 patients and 120 controls were examined for the presence of the variants detected. METHODS: All coding exons were sequenced in 16 cases. Eight ICP cases, including two women carrying a mutation, were investigated using in vivo hepatic (31)P magnetic resonance spectroscopy (MRS) RESULTS: Two heterozygous ATP8B1 transitions (208G>A and 2599C>T) that resulted in amino acid substitutions were identified; 208G>A was identified in three cases. MRS revealed an increased phosphodiester signal (Mann-Whitney U test, p = 0.03) and a decreased phosphomonoester/phosphodiester ratio (p = 0.04) in ICP cases compared with controls. CONCLUSIONS: We were able to demonstrate ATP8B1 mutations in ICP. MRS studies suggest that susceptibility to ICP is associated with a relative rise in biliary phospholipid. These data also suggest that MRS may be used for non-invasive assessment of the liver and biliary constituents in cholestasis.
Subject(s)
Adenosine Triphosphatases/genetics , Cholestasis, Intrahepatic/genetics , Mutation/genetics , Pregnancy Complications , Cholestasis, Intrahepatic/metabolism , Esters/metabolism , Female , Genetic Testing/methods , Heterozygote , Humans , Liver/metabolism , Magnetic Resonance Spectroscopy , Pregnancy , Pregnancy Complications/metabolism , Sequence AnalysisABSTRACT
The recognition of the importance and utility of single nucleotide polymorphisms has generated an interest in the development of new strategies for their identification. Analysis of the Expressed Sequence Tag (EST) database can provide a rapid and efficient means of identifying polymorphisms. Screening of the Alpha class glutathione transferases (GSTs) in the EST database identified 10 putative polymorphisms in the coding region of the GSTA1 and GSTA2 genes, six of which were subsequently verified by sequence analysis. Polymerase chain reaction/restriction fragment length polymorphism analysis revealed the existence of three variants, a silent base substitution, K125K (G365A) in GSTA1, and T112S and E210A in GSTA2, in European Australian, African and Chinese populations. The variant isoforms of GSTA2 were expressed in Escherichia coli, purified, and enzymatically characterized. Modelling of the two GSTA2 polymorphisms into a three-dimensional structure of GSTA2, and characterization of their enzymatic properties, has shown that the structure and function of the wild-type GSTA2-2 isoenzyme is not significantly altered by these polymorphisms. This report demonstrates that analysis of the EST database provides a rapid and efficient means of identifying variant proteins.
Subject(s)
Glutathione Transferase/genetics , Isoenzymes/genetics , Polymorphism, Genetic/genetics , Alleles , Asian People/genetics , Black People/genetics , Databases, Genetic , Expressed Sequence Tags , Glutathione Transferase/chemistry , Humans , Isoenzymes/chemistry , Native Hawaiian or Other Pacific Islander/genetics , Protein Structure, Quaternary/genetics , Structure-Activity Relationship , White People/geneticsABSTRACT
The human expressed sequence tag (EST) database can be searched by different sequence alignment strategies to identify new members of gene families and allelic variants. To illustrate the value of database analysis for gene discovery, we have focused on the glutathione S-transferase (GST) super family, an approach that has led to the identification of the Zeta class. The Zeta class GSTs catalyze the glutathione-dependent biotransformation of alpha-haloacids and the isomerization of maleylacetoacetic acid to fumarylacetoacetic acid, an essential step in the catabolism of tyrosine. Allelic variants of the GST Z1 and GST A2 genes have also been identified by EST database analysis. One GST Z1 variant (GST Z1A) has significantly higher activity with dichloroacetic acid as a substrate than other GST Z1 isoforms. This variant may be important in the clinical treatment of lactic acidosis where dichloroacetic acid is prescribed. Our experience with the application of EST database searching methods suggests that it may be productively applied to other gene families of pharmacogenetic interest.
Subject(s)
Database Management Systems , Expressed Sequence Tags , Glutathione Transferase/genetics , Polymorphism, Genetic , Amino Acid Sequence , Animals , Base Sequence , DNA , Humans , Molecular Sequence Data , Sequence Homology, Amino Acid , Sequence Homology, Nucleic AcidABSTRACT
The global genome research effort has resulted in the creation of extensive DNA and protein sequence databases that are a valuable resource for the identification of new genes and polymorphic variants of enzymes of pharmacogenetic interest. Previously undescribed members of gene families with novel functions and substrate specificities can be identified by database searching and sequence alignment strategies. Since the expressed sequence tag (EST) database contains sequences from many individuals, it can be searched for evidence of polymorphisms that can significantly influence enzyme function. The different approaches to these forms of analysis are reviewed and illustrated with examples from the glutathione transferase gene family.
Subject(s)
DNA/genetics , Databases, Factual , Pharmacogenetics , Phylogeny , Proteins/genetics , Animals , Base Sequence , DNA/chemistry , Expressed Sequence Tags , Humans , Molecular Sequence Data , Plants/genetics , Polymorphism, Genetic , Proteins/chemistry , Sequence AlignmentABSTRACT
In hereditary nonpolyposis colorectal cancer (HNPCC), the majority of reported mutations are dispersed throughout the 35 exons of the two principal susceptibility genes, MLH1 and MSH2, and because of this complexity, rapid mutation screening methods are required. The aim of this study was to evaluate the sensitivity of the Enzymatic Mutation Detection (EMD) assay in HNPCC using genomic DNA samples with known gene alterations in MLH1 and MSH2. The EMD assay relies upon the enzyme T4 Endonuclease VII recognizing and cleaving DNA mismatches, created when a PCR product containing a sequence alteration is hybridized with a wild type probe. A total of 68 different sequence variants from 30 exons were analyzed. The EMD assay was able to detect 62 of the 68 sequence variants (91%) with the majority showing strong cleavage products. One of the advantages of the EMD assay over other mutation screening techniques is that larger fragments can be analyzed in a single assay. No specialized equipment is required and one set of primers is sufficient for radioactive detection of the cleavage products. This method can be adapted to use fluorescent dye-labelled primers and may be automated to detect mutations accurately and rapidly in a large number of samples. One new MLH1 mutation (418delA) and two novel MSH2 mutations (1A>C; 227-228delAG) were also detected in HNPCC patients screened using this method.